BioTechne TECH Shows Modest Upside as Shares Rebound from Support Trumps Comments on Taiwan Independence Stir Geopolitical Uncertainty for Markets DAKT Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher RBIs 25 bps Rate Cut Dilutes Old Policy Framework Says Nomura